SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 03/15/21
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 03/12/21
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 03/11/21
ROSEN, A TOP RANKED LAW FIRM, Encourages Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation Investors to Secure Counsel Before Important Deadline – IMVT, HSACU, HSAC, HSACWGlobeNewsWire • 03/09/21
IMVT INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Immunovant, Inc.GlobeNewsWire • 03/07/21
ROSEN, A LEADING LAW FIRM, Encourages Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline – IMVT, HSACU, HSAC, HSACWBusiness Wire • 03/06/21
SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Immunovant, Inc. – IMVT, HSACU, HSAC, HSACWGlobeNewsWire • 03/05/21
IMVT Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Immunovant, Inc. Investors of Class Action and Encourages Shareholders to Contact the FirmBusiness Wire • 03/05/21
ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline – IMVT, HSACU, HSAC, HSACWGlobeNewsWire • 03/03/21
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation (IMVT)Business Wire • 03/03/21
IMVT INVESTOR DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Immunovant, Inc.GlobeNewsWire • 03/02/21
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation (IMVT)Business Wire • 03/01/21
BREAKING ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation Investors to Secure Counsel Before Important Deadline – IMVT, HSACU, HSAC, HSACWBusiness Wire • 02/25/21
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation (IMVT) InvestorsBusiness Wire • 02/25/21
IMVT INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Immunovant, Inc.GlobeNewsWire • 02/25/21
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation (IMVT) InvestorsBusiness Wire • 02/24/21
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation (IMVT) InvestorsBusiness Wire • 02/24/21
Shareholder Alert: Robbins LLP Announces That Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation (IMVT) is Being Sued for Misleading ShareholdersBusiness Wire • 02/23/21
The Law Offices of Frank R. Cruz Announces Investigation of Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation (IMVT) on Behalf of InvestorsBusiness Wire • 02/23/21
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation (IMVT) on Behalf of InvestorsBusiness Wire • 02/23/21
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation (IMVT) on Behalf of InvestorsBusiness Wire • 02/23/21
